allurion.com - נכסים נקיים למניה בודדת ALUR

Allurion Technologies (ALUR) is actively scaling its robotic capsules and AI weight management services. The business is moderately cyclical, although stable demand for obesity treatment offsets macroeconomic risks. The net book value per share reflects asset dynamics, with the parameter stabilizing at -10.63. High physician confidence confirms the company's status as a global innovator in non-surgical aesthetic medicine.

Book value per share reflects the residual value of a company's equity divided by the number of outstanding securities, serving as a fundamental indicator of the business's intrinsic value. By analyzing the BVPS metric on the GURU.Markets platform, an investor can see the tangible asset capitalization of Allurion Technologies (ALUR), including high-capacity production lines for innovative balloons, which confirms the actual value of the issuer's assets.